Scenarios that move URGN

UroGen Pharma Ltd. - Ordinary Shares

Scenarios that move URGN: 1 analysis, 0 positive, 1 negative.

  1. · FDA expands ImmunityBio's Anktiva label for bladder cancer — ▼ · impact -45 · confidence medium · horizon immediate

All scenarios · Run a scenario · Pricing